Timo Lischke

611 total citations
20 papers, 473 citations indexed

About

Timo Lischke is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Timo Lischke has authored 20 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Timo Lischke's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Timo Lischke is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Timo Lischke collaborates with scholars based in Germany, Singapore and Switzerland. Timo Lischke's co-authors include Andreas Hutloff, Richard A. Kroczek, Yvonne Burmeister, Kong‐Peng Lam, Hans Werner Mages, Anthony J. Coyle, Hans‐Willi Mittrücker, Friedrich Koch‐Nolte, Valéa Schumacher and M Schneider and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Timo Lischke

19 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timo Lischke Germany 11 324 121 89 70 40 20 473
Hiroaki Kaku United States 11 270 0.8× 49 0.4× 95 1.1× 54 0.8× 41 1.0× 21 443
Saša Radoja United States 14 543 1.7× 240 2.0× 166 1.9× 25 0.4× 47 1.2× 18 723
Kumi Izawa Japan 13 465 1.4× 79 0.7× 209 2.3× 27 0.4× 20 0.5× 29 734
Wim van Schooten United States 9 263 0.8× 184 1.5× 128 1.4× 118 1.7× 33 0.8× 22 594
Mark Biffen United Kingdom 13 299 0.9× 62 0.5× 229 2.6× 29 0.4× 33 0.8× 24 525
Laura Conter United States 6 310 1.0× 40 0.3× 111 1.2× 25 0.4× 39 1.0× 9 422
Jorge Postigo Spain 12 189 0.6× 51 0.4× 97 1.1× 22 0.3× 62 1.6× 24 388
Weiwei Ma China 11 451 1.4× 124 1.0× 122 1.4× 8 0.1× 35 0.9× 25 651
Gao Liu China 11 284 0.9× 151 1.2× 254 2.9× 15 0.2× 48 1.2× 17 650
M V Sitkovsky United States 12 325 1.0× 91 0.8× 142 1.6× 47 0.7× 48 1.2× 12 468

Countries citing papers authored by Timo Lischke

Since Specialization
Citations

This map shows the geographic impact of Timo Lischke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Lischke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Lischke more than expected).

Fields of papers citing papers by Timo Lischke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Lischke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Lischke. The network helps show where Timo Lischke may publish in the future.

Co-authorship network of co-authors of Timo Lischke

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Lischke. A scholar is included among the top collaborators of Timo Lischke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Lischke. Timo Lischke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Danielczyk, Antje, et al.. (2022). Abstract 316: Carbohydrate-dependent protein binding antibodies with superior tumor-specificity. Cancer Research. 82(12_Supplement). 316–316. 1 indexed citations
3.
Mohr, Elodie, Timo Lischke, Friedemann Paul, et al.. (2022). Bin‐based visualization of cytokine‐co‐expression patterns of IL‐10‐producing CD4 T cell subsets. European Journal of Immunology. 52(10). 1684–1687. 1 indexed citations
4.
Danielczyk, Antje, et al.. (2022). 1346 Antibodies against GlycoTargets as novel platform approach to address unmet needs in cancer therapy. Regular and Young Investigator Award Abstracts. A1397–A1397. 1 indexed citations
5.
Lischke, Timo, et al.. (2021). 712 Preclinical characterization of GT-00A x IL15: A novel IL-15-based immunocytokine with unique tumor targeting properties. SHILAP Revista de lepidopterología. A741–A741. 1 indexed citations
6.
Lischke, Timo, et al.. (2021). 781 GT-001 - anti-Lewis Y antibody with superior fine-specificity and reduced off-target binding. Regular and Young Investigator Award Abstracts. A816–A816. 2 indexed citations
7.
Lischke, Timo, Elodie Mohr, Detlef Groth, et al.. (2020). Identification of a super-functional Tfh-like subpopulation in murine lupus by pattern perception. eLife. 9. 6 indexed citations
8.
Reinicke, Anna T., Friederike Raczkowski, Timo Lischke, et al.. (2019). Deubiquitinating Enzyme UCH-L1 Promotes Dendritic Cell Antigen Cross-Presentation by Favoring Recycling of MHC Class I Molecules. The Journal of Immunology. 203(7). 1730–1742. 14 indexed citations
11.
Kociok, Norbert, Claudia Brockmann, Timo Lischke, et al.. (2017). Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells. Experimental Eye Research. 166. 56–69. 10 indexed citations
12.
Kociok, Norbert, Claudia Brockmann, Timo Lischke, et al.. (2017). Dataset on the activation of Müller cells through macrophages upon hypoxia in the retina. Data in Brief. 16. 489–500. 1 indexed citations
13.
Fuhrmann, Franziska, Timo Lischke, Fridolin Groß, et al.. (2016). Adequate immune response ensured by binary IL-2 and graded CD25 expression in a murine transfer model. eLife. 5. 18 indexed citations
14.
Schneider, M, Valéa Schumacher, Timo Lischke, et al.. (2015). CD38 Is Expressed on Inflammatory Cells of the Intestine and Promotes Intestinal Inflammation. PLoS ONE. 10(5). e0126007–e0126007. 41 indexed citations
15.
Carambia, Antonella, Kirsten Richter, Timo Lischke, et al.. (2014). CD4+ T-Cell Help Is Required for Effective CD8+ T Cell-Mediated Resolution of Acute Viral Hepatitis in Mice. PLoS ONE. 9(1). e86348–e86348. 18 indexed citations
16.
Kreher, Stephan, Katrin Lehmann, René Riedel, et al.. (2014). Nuclear Factor of Activated T Cells Regulates the Expression of Interleukin-4 in Th2 Cells in an All-or-none Fashion. Journal of Biological Chemistry. 289(39). 26752–26761. 20 indexed citations
17.
Lischke, Timo, Valéa Schumacher, M Schneider, et al.. (2013). CD38 Controls the Innate Immune Response against Listeria monocytogenes. Infection and Immunity. 81(11). 4091–4099. 68 indexed citations
18.
Lischke, Timo, Valéa Schumacher, Janusz Wesolowski, et al.. (2013). CD8‐β ADP‐ribosylation affects CD8+T‐cell function. European Journal of Immunology. 43(7). 1828–1838. 20 indexed citations
19.
Lischke, Timo, Stephanie Gurka, Dana Vu Van, et al.. (2012). Comprehensive Analysis of CD4+ T Cells in the Decision between Tolerance and Immunity In Vivo Reveals a Pivotal Role for ICOS. The Journal of Immunology. 189(1). 234–244. 13 indexed citations
20.
Burmeister, Yvonne, Timo Lischke, Hans Werner Mages, et al.. (2008). ICOS Controls the Pool Size of Effector-Memory and Regulatory T Cells. The Journal of Immunology. 180(2). 774–782. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026